Skip to main content
. 2024 Apr 17;30(13):2693–2701. doi: 10.1158/1078-0432.CCR-23-3567

Figure 2.

Figure 2.

Waterfall plot of all evaluable participants according to indication (A) and spider plot of participants with head and neck tumors (including SCC and adenocarcinoma), SCC with various primary origins, and melanoma (B). Sum of the diameter of target lesions post-baseline was not available for three patients. aPositive PDL1 status was defined as TC or IC > 0; bthe participant with head and neck cancer who experienced a CR had SCC of the head and neck; the other five cases of head and neck cancer were adenocarcinomas. NE, not evaluable; PD, progressive disease; SLD, sum of (target) lesion; Ukn, unknown.